[PDF][PDF] Liver macrophages: old dogmas and new insights

A Guillot, F Tacke - Hepatology communications, 2019 - Wiley Online Library
Inflammation is a hallmark of virtually all liver diseases, such as liver cancer, fibrosis,
nonalcoholic steatohepatitis, alcoholic liver disease, and cholangiopathies. Liver …

Monocytes and macrophages as viral targets and reservoirs

E Nikitina, I Larionova, E Choinzonov… - International journal of …, 2018 - mdpi.com
Viruses manipulate cell biology to utilize monocytes/macrophages as vessels for
dissemination, long-term persistence within tissues and virus replication. Viruses enter cells …

Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure

MC Nielsen, R Hvidbjerg Gantzel, J Clària, J Trebicka… - Cells, 2020 - mdpi.com
Macrophages facilitate essential homeostatic functions eg, endocytosis, phagocytosis, and
signaling during inflammation, and express a variety of scavenger receptors including …

Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment

S Dash, Y Aydin, KE Widmer… - Journal of hepatocellular …, 2020 - Taylor & Francis
Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

A tale of two viruses: immunological insights into HCV/HIV coinfection

ST Gobran, P Ancuta, NH Shoukry - Frontiers in immunology, 2021 - frontiersin.org
Nearly 2.3 million individuals worldwide are coinfected with human immunodeficiency virus
(HIV) and hepatitis C virus (HCV). Odds of HCV infection are six times higher in people living …

Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

TL Laursen, CB Siggaard, K Kazankov… - Journal of viral …, 2020 - Wiley Online Library
Sofosbuvir‐based direct‐acting antiviral (DAA) therapy generally cures chronic hepatitis C
(CHC) infections, however, the effects on the underlying liver disease and the potential rate …

Macrophage activation markers, soluble CD163 and mannose receptor, in liver fibrosis

RH Gantzel, MB Kjær, TL Laursen, K Kazankov… - Frontiers in …, 2021 - frontiersin.org
Macrophages are essential components of the human host immune system, which upon
activation facilitates a broad pallet of immunomodulatory events including release of pro-or …

Identifying high-risk NASH patients: what we know so far

M Schulz, F Tacke - Hepatic Medicine: Evidence and Research, 2020 - Taylor & Francis
Steatosis is a condition of hepatic fat overload that is associated with overweight and the
metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) has become the most …

[HTML][HTML] Circulating macrophage activation markers predict transplant-free survival in patients with primary sclerosing cholangitis

L Bossen, M Vesterhus, JR Hov… - Clinical and …, 2021 - journals.lww.com
METHODS: We investigated 2 independent PSC cohorts from Oslo (n= 138) and Helsinki
(n= 159) and analyzed blood sCD163 and sMR levels. The Mayo score, Enhanced Liver …

Hepatitis C virus and the host: a mutual endurance leaving indelible scars in the host's immunity

MU Mondelli, S Ottolini, B Oliviero, S Mantovani… - International Journal of …, 2023 - mdpi.com
Hepatitis C virus (HCV) has spread worldwide, and it is responsible for potentially severe
chronic liver disease and primary liver cancer. Chronic infection remains for life if not …